the value of thrombolytic treatment in patients 75 years of age or older remains controversial. This is due in part to conflicting data from clinical trials and observational studies and in part ...

The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective treatments for patients with stroke are well documented, with issues including ...

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

Keeping time to imaging to a minimum in these patients may, therefore, help to identify candidates for thrombolysis treatment. The standard application of features to guide management of stroke is ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

Artificial intelligence is revolutionizing stroke management by improving diagnosis, accelerating treatment, enabling remote ...

which cleaves the fibrin cross-links causing thrombus breakdown. Fibrinolytic therapy is used in the treatment of a ST segment elevation myocardial infarction (STEMI), acute stroke and other less ...

The American Stroke Association (ASA) announced the presentation of the DISTAL study, which is investigating whether endovascul ...

Chinese clinical scientist Wang Yongjun has been granted the William M. Feinberg Award for Excellence in Clinical Stroke at the 2025 International Stroke Conference (ISC) held in Los Angeles on ...

Typically, an ischaemic stroke patient was 115 kilometres away from the nearest intravenous thrombolysis treatment centre and about 130 kilometres away from the nearest endovascular therapy centre ...